GLP-1 stimulates glucose-derived de novo fatty acid synthesis and chain elongation during cell differentiation and insulin release

Journal of Lipid Research

Volumn 44, Issue 8, 2003, Pages 1559-1565

  Bulotta, Angela ^a   Perfetti, Riccardo ^a   Hui, Hongxiang ^a   Boros, László G ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucagon like peptide 1; Insulin production; Mass spectrometry; Pentose cycle; SIDMAP; Stable isotope trace; Stable isotope based dynamic metabolic profiling

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; PALMITIC ACID;

AGING; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FATTY ACID SYNTHESIS; GAS CHROMATOGRAPHY; GLUCOSE TOLERANCE; HOMEOBOX; INSULIN RELEASE; MASS SPECTROMETRY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; CARBON ISOTOPES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; FATTY ACIDS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; PANCREAS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RATS;

EID: 0142074274     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300093-JLR200     Document Type: Article

References (29)

1. Dachicourt, N., P. Serradas, D. Bailbe, M. Kergoat, L. Doare, and B. Portha. 1997. Glucagon-like peptide-1 (7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies. J. Endocrinol. 155: 369-376.
2. Montrose-Rafizadeh, C., Y. Wang, A. M. Janczewski, T. E. Henderson, and J. M. Egan. 1997. Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness. Mol. Cell. Endocrinol. 130: 109-117.
3. Hui, H., C. Wright, and R. Perfetti. 2001. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes. 50: 785-796.
4. Zhou, J., C. Montrose-Rafizadeh, A. M. Janczewski, M. A. Pineyro, S. J. Sollott, Y. Wang, and J. M. Egan. 1999. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells. J. Cell. Physiol. 181: 470-478.
5. Salapatek, A. M., P. E. MacDonald, H. Y. Gaisano, and M. B. Wheeler. 1999. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-TI5 cells. Mol. Endocrinol. 13: 1305-1317.
6. Wang, X., J. Zhou, M. E. Doyle, and J. M. Egan. 2001. Glucagon like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology. 142: 1820-1827.
7. Hussain, M. A., and J. F. Habaner. 2000. Glucagon-like peptide-1 increases glucose-dependent activity of the homeoprotein PDX-1 transactivating domain in pancreatic beta cells. Biochem. Biophys. Res. Commun. 274: 616-619.
8. Cascante, M., L. G. Boros, B. Comin-Anduix, P. de Atauri, J. J. Centelles, and P. W. Lee. 2002. Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. 20: 243-249.
9. Boros, L. G., M. Cascante, and W. N. Paul Lee. 2002. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. DrugDiscov. Today. 7: 364-372.
10. Boros, L. G., J. S. Torday, S. Lim, S. Bassilian, M. Cascante, and W. N. Lee. 2000. Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res. 60: 1183-1185.
11. Boren, J., M. Cascante, S. Marin, B. Comin-Anduix, J. J. Centelles, S. Lim, S. Bassilian, S. Ahmed, W. N. Lee, and L. G. Boros. 2001. Gleevec (ST1571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem. 276: 37747-37753.
12. Boros, L. G., K. Lapis, B. Szende, R. Tomoskozi-Farkas, A. Balogh, J. Boren, S. Marin, M. Cascante, and M. Hidvegi. 2001. Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells. Pancreas. 23: 141-147.
13. Comin-Anduix, B., L. G. Boros, S. Marin, J. Boren, C. Callol-Massot, J. J. Centelles, J. L. Torres, N. Agell, S. Bassilian, and M. Cascante. 2002. Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. J. Biol. Chem. 277: 46408-46414.
14. 13C]urea breath tests for Helicobacter pylori by gas chromatography-mass spectrometry in the selected ion monitoring mode. Aliment. Pharmacol. Ther. 10: 985-995.
15. Neese, R. A., S. Q. Siler, D. Cesar, F. Antelo, D. Lee, L. Misell, K. Patel, S. Tehrani, P. Shah, and M. K. Hellerstein. 2001. Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Anal. Biochem. 298: 189-195.
16. 2] glucose. Am. J. Physiol. 274: E843-E851.
17. Lee, W. N., J. Edmond, S. Bassilian, and J. W. Morrow. 1996. Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. Dev. Neurosci. 18: 469-477.
18. Leimer, K. R., R. H. Rice, and C. W. Gehrke. 1977. Complete mass spectra of N-TAB esters of amino acids. J. Cromatogr. 141: 121-144.
19. Lee, W. N. 1996. Stable isotopes and mass isotopomer study of fatty acid and cholesterol synthesis. A review of the MIDA approach. Adv. Exp. Med. Biol. 399: 95-114.
20. Khaksa, G., K. Nalini, M. Bhat, and N. Udupa. 1998. High-performance liquid chromatographic determination of insulin in rat and human plasma. Anal. Biochem. 260: 92-95.
21. Takhar, S., S. Gyomorey, R. C. Su, S. K. Mathi, X. Li, and M. B. Wheeler. 1996. The third cytoplasmic domain of the GLP-1 [7-36 amide] receptor is required for coupling to the adenylyl cyclase system. Endocrinology. 137: 2175-2178.
22. Gishizky, M. L., and G. M. Grodsky. 1987. Differential kinetics of rat insulin I and II processing in rat islets of Langerhans. FEBS Lett. 223: 227-231.
23. Agerso, H., L. B. Jensen, B. Elbrond, P. Rolan, and M. Zdravkovic. 2002. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia. 45: 195-202.
24. Schoonjans, K., B. Staels, and J. Auwerx. 1996. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302: 93-109.
25. Gong, T. W., D. J. Meyer, J. Liao, C. L. Hodge, G. S. Campbell, X. Wang, N. Billestrup, C. Carter-Su, and J. Schwartz. 1998. Regulation of glucose transport and c-fos and egr-I expression in cells with mutated or endogenous growth hormone receptors. Endocrinology. 139: 1863-1871.
26. Prentki, M., E. Joly, W. El-Assaad, and R. Roduit. 2002. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes. 51 (Suppl 3): S405-S413.
27. Zhou, Y. T., M. Shimabukuro, Y. Lee, K. Koyama, M. Higa, T. Ferguson, and R. H. Unger. 1998. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes. 47: 1904-1908.
28. Hashiguchi, S., T. Yada, and T. Arima. 2001. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1 (7-36) amide and pituitary adenylate cyclase-activating polypeptide. J. Pharmacol. Exp. Ther. 296: 22-30.
29. Lee, W. N., S. Lim, S. Bassilian, E. A. Bergner, and J. Edmond. 1998. Fatty acid cycling in human hepatoma cells and the effects of troglitazone. J. Biol. Chem. 273: 20929-20934.